Skip to content
OpenCapital
Get started

LONA LONA Cash & Equivalents

Cash & Equivalents at other companies

Eli Lilly logo
Eli LillyLLY
$5.28B+70.8%
Arvinas logo
ArvinasARVN
$87.3M+7.8%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$52.55M+3.8%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$84.79M+122%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$161.66M-25.3%
Erasca, Inc. logo
Erasca, Inc.ERAS
$47.26M-33.0%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+235%
Enterprise value$54.18M—

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0×0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's cash & equivalents?
LONA (LONA) reported cash & equivalents of $32.83M in Q1 2026.
How has LONA's cash & equivalents changed year-over-year?
LONA's cash & equivalents increased by 24.3% year-over-year, from $26.42M to $32.83M.
What is the long-term trend for LONA's cash & equivalents?
Over 5 years (2020 to 2025), LONA's cash & equivalents has grown at a 2.7% compound annual growth rate (CAGR), from $60.63M to $69.28M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.